Literature DB >> 7437013

Properties of monoamine oxidase in control and Lesch-Nyhan fibroblasts.

M R Castro Costa, S B Edelstein, C M Castiglione, H Chao, X O Breakefield.   

Abstract

Monoamine oxidase activity of the A type was measured in homogenates of cultured human skin fibroblasts. Twenty-four control lines had activities ranging over fifty-fold with an apparent bimodal distribution. Activity in fibroblasts from 20 patients with the Lesch-Nyhan syndrome fell in the low portion of the normal distribution with a mean activity about 50% that of the control mean (p < 0.05). In a subgroup of control and Lesch-Nyhan lines with levels of enzyme activity from 0.9 to 179 pmol/min/mg protein, monoamine oxidase was similar with respect to apparent Km for tryptamine, thermal stability at 56 C, and sensitivity to clorgyline. Thus the lower mean levels of activity observed in the Lesch-Nyhan as compared to control fibroblasts were not associated with other altered properties of the enzyme. The bimodal distribution of enzyme activity suggests that a genetic polymorphism for monoamine oxidase may control levels of activity expressed in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437013     DOI: 10.1007/bf00484403

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  37 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Enzyme inhibition in relation to chemotherapy.

Authors:  W W ACKERMANN; V R POTTER
Journal:  Proc Soc Exp Biol Med       Date:  1949-10

3.  Hypoxanthine-guanine phosphoribosyltransferase mutant glioma cells: diminished monamine oxidase activity.

Authors:  S D Skaper; J E Seegmiller
Journal:  Science       Date:  1976-12-10       Impact factor: 47.728

4.  Monoamine oxidase A and B in cultured cells.

Authors:  M Hawkins; X O Breakefield
Journal:  J Neurochem       Date:  1978-06       Impact factor: 5.372

Review 5.  Low platelet monoamine oxidase activity and schizophrenia.

Authors:  R J Wyatt; D L Murphy
Journal:  Schizophr Bull       Date:  1976       Impact factor: 9.306

6.  Platelet monoamine oxidase in chronic schizophrenia.

Authors:  W H Berrettini; W H Vogel; R Clouse
Journal:  Am J Psychiatry       Date:  1977-07       Impact factor: 18.112

Review 7.  Substrate-selective monoamine oxidases--inhibitor, tissue, species and functional differences.

Authors:  D L Murphy
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

8.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

9.  Monoamine oxidase activity in normal and Lesch-Nyhan fibroblasts.

Authors:  S B Edelstein; C M Castiglione; X O Breakfield
Journal:  J Neurochem       Date:  1978-11       Impact factor: 5.372

10.  Chromosome-mediated gene transfer between closely realted strains of cultured mouse cells.

Authors:  G E Degnen; I L Miller; J M Eisenstadt; E A Adelberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

View more
  13 in total

Review 1.  Lesch-Nyhan Syndrome: Models, Theories, and Therapies.

Authors:  Scott Bell; Ilaria Kolobova; Liam Crapper; Carl Ernst
Journal:  Mol Syndromol       Date:  2016-09-24

2.  Isolation and compositional analysis of secretion granules and their membrane subfraction from the rat parotid gland.

Authors:  R S Cameron; J D Castle
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

3.  Effect of riboflavin on monoamine oxidase activity in cultured neuroblastoma cells.

Authors:  V Bonnefil; C M Castiglione; R M Cawthon; X O Breakefield
Journal:  Cell Mol Neurobiol       Date:  1981-12       Impact factor: 5.046

4.  Screen for MAOA mutations in target human groups.

Authors:  D E Schuback; E L Mulligan; K B Sims; E A Tivol; B D Greenberg; S F Chang; S L Yang; Y C Mau; C Y Shen; M S Ho; N H Yang; M G Butler; S Fink; C E Schwartz; F Berlin; X O Breakefield; D L Murphy; Y P Hsu
Journal:  Am J Med Genet       Date:  1999-02-05

5.  Human monoamine oxidase A gene determines levels of enzyme activity.

Authors:  G S Hotamisligil; X O Breakefield
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

Review 6.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

7.  Structure of the human gene for monoamine oxidase type A.

Authors:  Z Y Chen; G S Hotamisligil; J K Huang; L Wen; D Ezzeddine; N Aydin-Muderrisoglu; J F Powell; R H Huang; X O Breakefield; I Craig
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

8.  Monoamine oxidase (MAO) activity as a determinant in human neurophysiology.

Authors:  J E Pintar; X O Breakefield
Journal:  Behav Genet       Date:  1982-02       Impact factor: 2.805

9.  Norrie disease gene is distinct from the monoamine oxidase genes.

Authors:  K B Sims; L Ozelius; T Corey; W B Rinehart; R Liberfarb; J Haines; W J Chen; R Norio; E Sankila; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

10.  Lesch-Nyhan disease causes impaired energy metabolism and reduced developmental potential in midbrain dopaminergic cells.

Authors:  Scott Bell; Vincent McCarty; Huashan Peng; Malvin Jefri; Nuwan Hettige; Lilit Antonyan; Liam Crapper; Liam A O'Leary; Xin Zhang; Ying Zhang; Hanrong Wu; Diane Sutcliffe; Ilaria Kolobova; Thad A Rosenberger; Luc Moquin; Alain Gratton; Jelena Popic; Ilse Gantois; Patrick S Stumpf; Andreas A Schuppert; Naguib Mechawar; Nahum Sonenberg; Michel L Tremblay; Hyder A Jinnah; Carl Ernst
Journal:  Stem Cell Reports       Date:  2021-07-01       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.